e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Monitoring asthma: genes, cells and molecules
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled nitric oxide and the therapeutic regimens in childhood asthma
R. Diaconu, L. Stanescu, C. Diaconu, G. Calin (Craiova, Romania)
Source:
Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Session:
Monitoring asthma: genes, cells and molecules
Session type:
Thematic Poster Session
Number:
1119
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Diaconu, L. Stanescu, C. Diaconu, G. Calin (Craiova, Romania). Exhaled nitric oxide and the therapeutic regimens in childhood asthma. Eur Respir J 2013; 42: Suppl. 57, 1119
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Cost savings using fractional exhaled nitric oxide (FeNO) testing in asthma management by specialists
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Exhaled nitric oxide variations during oral challenge with different NSAIDs in patients with aspirin-induced asthma
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
Exhaled nitric oxide in asthma: Relationship with breath gymnastic and FeNO levels
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Exhaled nitric oxide in childhood asthma
Source: Annual Congress 2006 - Paediatric Respiratory Research Award
Year: 2006
Non-adherence to inhaled corticosteroid therapy as an explanation for persistently elevated exhaled nitric oxide levels in patients with asthma: Effect of directly observed therapy with inhaled corticosteroids (DOT-ICS)
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Exhaled NO levels – A new tool in decision-making about antibiotic treatment
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
The levels of exhaled nitric oxide in controlled asthmatic patients with and without rhinitis
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Exhaled nitric oxide, susceptibility and new-onset asthma in the Children’s Health Study
Source: Eur Respir J 2011; 37: 523-531
Year: 2011
Further evidence that FeNO directed therapy reduces asthma exacerbations
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma
Source: Eur Respir J 2010; 35: 1221-1227
Year: 2010
Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Validation of ATS guidelines for FeNO to monitor eosinophillic airway inflammation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Relationships between exhaled nitric oxide and atopic profiles (mono-sensitization/poly-sensitization) in asthmatic patients
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Weak association between exhaled nitric oxide and bronchial responsiveness in asthmatic patients
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Interaction between airway calibre and exhaled NO: Impact on asthma control assessment
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept